LTL Pharma proactively seeks an opportunity of alliance with other pharmaceutical company to develop business both in Japan and overseas.
We continue to make efforts to enrich our portfolio of long-life medicines going forward through transfer of marketing authorizations as well as distribution from other companies.
Adding new therapeutic areas to the primary care focused in the current portfolio, we aim to expand our future portfolio and further develop overseas business with these products as well.
LTL Pharma also strengthens alliance for active pharmaceutical ingredients and other ingredients to ensure even more stable supply.
